Cameron Turtle

Cameron Turtle is an accomplished executive in the pharmaceutical and biotechnology industries, currently serving as a Member of the Board of Directors at Oruka Therapeutics and the Chief Executive Officer at Spyre Therapeutics since June 2023. With prior experience as a Venture Partner at Foresite Labs and various leadership roles at BridgeBio including Chief Strategy Officer, Senior Vice President of Portfolio Management, and Director of Portfolio Management, Cameron has demonstrated expertise in strategic business development. Additionally, Cameron served as Chief Business Officer at Eidos Therapeutics and held an Associate position at McKinsey & Company, focusing on M&A, growth strategy, and clinical trial optimization. Cameron holds a DPhil in Cardiovascular Medicine from the University of Oxford and a BS in Bioengineering with a minor in Mathematics from the University of Washington.